Login / Signup
Could we apply the criteria of DAWN and DEFUSE-3 trials for slow progressors, beyond 24 h?
François Delvoye
Jean-Philippe Desilles
Mikael Mazighi
Published in:
Acta neurologica Belgica (2020)
Keyphrases
</>